NEW YORK (GenomeWeb News) – Orchid Cellmark said today that it has bought Strand Analytical Laboratories’ paternity and immigration DNA testing business unit for an undisclosed sum.
Indianapolis-based Strand provides forensic, medical, and paternity testing services.
This deal gives Orchid Cellmark Strand’s government paternity, private paternity, and immigration accounts, which last year had revenues of around $450,000.
Orchid Cellmark, headquartered in Princeton, NJ, said that it plans to support these new accounts from its Dayton, Ohio, paternity services facility. Strand will continue to support the clients for its other DNA testing business units.
"While Strand’s paternity business is relatively small in size, the acquisition is consistent with our strategy to grow revenues," Orchid Cellmark CEO and President Thomas Bologna said in a statement.
Financial terms of the agreement were not released.